Out Sourcing

Changes within the pharmaceutical industry are creating new challenges and opportunities for pharmaceutical companies as they strive to continue generating above-average returns. Scientific advances - in particular, the study of the human genome -- are leading to an improved understanding of the genetic causes of diseases, enabling companies to develop new drugs for previously untreated conditions. In addition, blockbuster drugs that can represent 50-60% of pharmaceutical sales are coming off patent within the next few years. With the expiration of more than 50 patents by 2005, pharmaceutical companies are under intense pressure to replace these drugs with new ones.

Both of these trends are creating a need for increased investment in research and development to keep the new drug pipelines flowing. The cost of R&D, however, is soaring -- almost doubling in the past five years. It is estimated, for example, that the cost of bringing a new drug to market today is more than US$600 million.

Pharmaceutical companies used to manufacture all products internally, building new facilities as business grew. Historically, the use of third parties to develop and manufacture drugs was confined to providing access to resources not available internally or to providing resources during peak times.

Today, outsourcing is being used more strategically - as an ongoing part of a company's overall business strategy, providing a means by which large pharmaceutical companies can divert their resources to the areas that produce maximum value for their shareholders: R&D and marketing.

Outsourcing with a third-party partner such as Sirius Pharma enables pharmaceutical companies to :
	Improve manufacturing efficiencies
	Reduce excess production capacity by divesting facilities
	Minimize investments in capital-intensive facilities
	Improve net earnings and cash flow
	Divert resources to focus on their core competencies: R&D and marketing......creating increased value for shareholders.

It is estimated that the U.S. market for outsourced pharmaceutical manufacturing is growing at the rate of 10 to 12% annually. Pharmaceutical companies will continue to fuel much of this growth as they outsource an increasing number of products and services. If you have to continue product development, yet have to cut costs, what do you do? Outsource from a reliable, cost effective destination. According to a report in the US, 29% of all companies with sales over $ 10 million are now outsourcing and 25% below $ 10 million are planning for it

And many of them eye India for the simple reason :
	Extremely Cost Effective
	Optimize your process, improving of yields or scaling
	Vast & talented technical pool & resources
	Handling of hazardous reactions & processes
	Facilities having GMP certified units

At Sirius Pharmaceuticals Pvt. Ltd., we work hand in hand with your company to make your idea a reality. As one of the leading contract manufacturing companies, we have the reputation, the expertise and the resources for added flexibility and improved results. Let us become your trusted partners in commercializing your idea, to success